Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors

Summary

Establish safety and toxicity profile and preliminary response rate of CPI-0610 in MPNST patients and correlate response with pharmacodynamics markers and BET inhibition.

Timeline

Start

2017-05-05

Primary completion

2018-05-17

Completion

2018-05-17

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of enrollment.”

Drugs

Indications